Breathing new hope: inhaled TB treatment enters human testing
Disease control
Recruiting now
This trial is testing whether an inhaled treatment called RESP30TB is safe and shows early signs of fighting tuberculosis bacteria. It involves 24 adults with newly diagnosed, drug-susceptible lung TB who will receive the treatment through a nebulizer. The main goals are to check…
Phase: PHASE2 • Sponsor: Thirty Respiratory Limited • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC